UK Adopts One-Dose Guideline for HPV Vaccination

by worldysnews


Own elaboration from various sources

  • Introduction
  • The process of changing the HPV vaccination regimen in the United Kingdom [ver]
  • Vaccination against HPV in the United Kingdom from next September [ver]
  • What will HPV vaccination be like in the UK from next September? [ver]
  • Advantages of the one-dose regimen [ver]
  • More information on this website, bibliographical references and recommended links [ver]
In a nutshell
  • The WHO in December 2022 established that the guidelines of one or two doses in adolescents and young people from 9 to 20 years of age provide equivalent protection against HPV.
  • Several countries have already taken the step and have changed their vaccination programs, adopting the one-dose regimen. The United Kingdom will do so next September.
  • A little over a year ago, the United Kingdom began the evaluation and decision process that has culminated in this important change. This process has included, in addition to the necessary evaluation of the accumulated evidence, a prior public consultation open to professionals, the population and interested entities of any kind, and, now, in this month of June, a complete and timely information campaign for several months before the implementation of the measure.
  • From September 2023, in the UK, vaccination of adolescents and young people up to the age of 25 will include a single dose of the 9-valent HPV vaccine.
  • This measure will result in a notable improvement in the acceptance of vaccination and a reduction in costs, which will contribute to the final objective, that of eliminating HPV-associated diseases, especially cervical cancer in women.



In the past year, 2022, we highlighted on this website several relevant facts regarding vaccination against the human papillomavirus (HPV):

  • The WHO evaluated the one-dose vaccination regimen, and in December, concluded by establishing that both regimens, one or two doses between 9 and 20 years of age, are equally effective and valid.
  • The UK begins the process of switching to a single-dose vaccination schedule.
  • Japan recovers, after years of suspension, the active vaccination recommendation.
  • In Spain, Catalonia was the pioneer community in announcing the implementation of the vaccination of male adolescents (Communities of Valencia, Galicia and Murcia joined the initiative in September 2022). And in December, finally, the CISNS decides to include the vaccination of male adolescents from January 2023 in all communities.

As of 2023, Australia, Cape Verde, Bangladesh, the Solomon Islands, Mexico, Nigeria and Tonga have already adopted (or are in the process of adopting) the single-dose vaccination schedule, and the United Kingdom (UK) is now the country that takes the definitive step in the same direction: the regimen of a single dose of HPV vaccine in adolescents and young people up to 25 years of age. Some details of the latter are presented below.

[volver al principio]

The process of changing the HPV vaccination regimen in the United Kingdom

The content provided in the HTML file includes CSS styling and various elements such as images and tables. The main sections of the content are an introduction, information on changing the HPV vaccination regimen in the UK, advantages of the one-dose regimen, and additional information and references. In summary, the content explains that the World Health Organization has determined that one or two doses of the HPV vaccine provide equivalent protection. Many countries, including the UK, have switched to a one-dose regimen, which will be implemented starting September 2023. The UK has gone through an evaluation and decision-making process, including public consultation and an information campaign, before making this change.

What steps did the UK take before implementing the one-dose regimen for the HPV vaccine?

The UK took the following steps before implementing the one-dose regimen for the HPV vaccine:

1. Review of scientific evidence: The UK conducted a thorough review of scientific evidence on the efficacy and safety of the HPV vaccine, particularly for a one-dose regimen. This included studies from clinical trials and real-world data.

2. Consultation with experts: The UK sought advice from experts in the field of HPV vaccination, including epidemiologists, immunologists, and vaccine experts. These experts provided insights on the feasibility and potential benefits of a one-dose regimen.

3. Evaluation of cost-effectiveness: The UK evaluated the cost-effectiveness of implementing a one-dose regimen compared to the existing two or three-dose regimens. This involved assessing the potential economic impact and benefits associated with reducing the number of doses required.

4. Assessment of vaccine supply and logistics: The UK considered the current vaccine supply and logistics, ensuring that an adequate number of doses would be available for implementing the one-dose regimen. They also assessed the feasibility of delivering the vaccine effectively with the new dosage schedule.

5. Decision-making process: Based on the evidence, expert advice, cost-effectiveness analysis, and logistical considerations, the UK made a decision to implement the one-dose regimen for the HPV vaccine.

It’s important to note that the specific steps may vary slightly depending on the country and its healthcare system.

You may also like


Nash June 26, 2023 - 6:26 am

This progressive decision by the UK to adopt a one-dose guideline for HPV vaccination is a significant step towards increasing accessibility and protecting more individuals against cervical cancer. A commendable move that will undoubtedly benefit public health.

Kristian June 26, 2023 - 6:26 am

This new guideline by the UK to adopt a one-dose regimen for HPV vaccination is a positive step towards increasing accessibility and effectiveness in combating this prevalent virus. It holds the potential to significantly reduce the burden of HPV-related diseases and protect more individuals.


Leave a Comment

Wrodlys News